Teachers Advisors’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2019
Q1 | $37M | Buy |
420,145
+127,570
| +44% | +$11.2M | 0.05% | 405 |
|
2018
Q4 | $20.9M | Buy |
292,575
+29,574
| +11% | +$2.11M | 0.03% | 583 |
|
2018
Q3 | $32.3M | Sell |
263,001
-175
| -0.1% | -$21.5K | 0.04% | 508 |
|
2018
Q2 | $25.9M | Buy |
263,176
+20,817
| +9% | +$2.05M | 0.03% | 598 |
|
2018
Q1 | $20.1M | Buy |
242,359
+48,964
| +25% | +$4.06M | 0.03% | 697 |
|
2017
Q4 | $15M | Buy |
193,395
+94,154
| +95% | +$7.31M | 0.02% | 871 |
|
2017
Q3 | $6.08M | Buy |
99,241
+7,691
| +8% | +$471K | 0.01% | 1239 |
|
2017
Q2 | $4.21M | Buy |
91,550
+8,903
| +11% | +$410K | 0.01% | 1413 |
|
2017
Q1 | $3.58M | Buy |
82,647
+4,360
| +6% | +$189K | 0.01% | 1469 |
|
2016
Q4 | $3.03M | Buy |
78,287
+4,668
| +6% | +$181K | ﹤0.01% | 1550 |
|
2016
Q3 | $3.73M | Buy |
73,619
+1,166
| +2% | +$59K | 0.01% | 1375 |
|
2016
Q2 | $3.29M | Sell |
72,453
-152,760
| -68% | -$6.94M | 0.01% | 1371 |
|
2016
Q1 | $8.91M | Sell |
225,213
-113,957
| -34% | -$4.51M | 0.02% | 913 |
|
2015
Q4 | $19.2M | Buy |
339,170
+5,746
| +2% | +$325K | 0.04% | 552 |
|
2015
Q3 | $13.3M | Sell |
333,424
-16
| -0% | -$637 | 0.03% | 716 |
|
2015
Q2 | $15.9M | Buy |
333,440
+12,739
| +4% | +$608K | 0.03% | 670 |
|
2015
Q1 | $12.7M | Buy |
320,701
+216,747
| +209% | +$8.61M | 0.02% | 788 |
|
2014
Q4 | $2.32M | Hold |
103,954
| – | – | ﹤0.01% | 1526 |
|
2014
Q3 | $1.63M | Sell |
103,954
-3,800
| -4% | -$59.5K | ﹤0.01% | 1734 |
|
2014
Q2 | $1.6M | Buy |
107,754
+9,599
| +10% | +$142K | ﹤0.01% | 1784 |
|
2014
Q1 | $1.58M | Buy |
98,155
+2,330
| +2% | +$37.5K | ﹤0.01% | 1747 |
|
2013
Q4 | $895K | Buy |
95,825
+3,880
| +4% | +$36.2K | ﹤0.01% | 2063 |
|
2013
Q3 | $1.04M | Buy |
91,945
+3,532
| +4% | +$40K | ﹤0.01% | 1902 |
|
2013
Q2 | $1.18M | Buy |
+88,413
| New | +$1.18M | ﹤0.01% | 1756 |
|